Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.
The company today priced its public offering of 4,054,055 shares at $18.50 per share.
Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.
RAPT has traded in the range of $9.85- $40.74 in the last 1 year.
Source: Read Full Article
Lates News:
-
Kala Pharmaceuticals Ascends 5% On Getting Fast Track Designation For Its KPI-012
-
$BTC: On-Chain Analyst Willy Woo Mocks Peter Schiff for Advising People To Sell Bitcoin
-
Analytics Firm Santiment Highlights Market Fear as Potential Bitcoin Rebound Indicator
-
Greenpeace Says Bitcoin Is ‘Defiantly Refusing To Accept Its Climate Responsibility’
-
$BTC: Popular Crypto Analyst Points to Bullish Pattern Suggesting Bitcoin Could Trade at $80,000 Next Year